论文部分内容阅读
最近在法国召开的“欧洲癌症会议”上,英国皇家马斯登医院和癌症研究院的David Cunningham 报告称,卡培他宾(商品名希罗达) 加吉西他宾能明显延长晚期胰腺癌患者的存活期。卡培他宾是一种口服药,在体内代谢成5-氟尿嘧啶。研究人员首次证明了一种细胞毒性药与另一种
At the recent European Cancer Conference in France, David Cunningham of Royal Marsden Hospital and Cancer Institute in the UK reported that capecitabine (trade name Xeloda) plus gemcitabine significantly prolonged advanced pancreatic cancer Patient’s survival period. Capecitabine is an oral medication that is metabolized in the body to 5-Fluorouracil. Researchers first demonstrated one cytotoxic drug with another